tiprankstipranks
Trending News
More News >
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
UK Market

SkinBioTherapeutics (SBTX) Financial Statements

Compare
22 Followers

SkinBioTherapeutics Financial Overview

SkinBioTherapeutics's market cap is currently £53.08M. The company's EPS TTM is p0.001; its P/E ratio is -62.12; SkinBioTherapeutics is scheduled to report earnings on December 5, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 4.64M£ 1.21M£ 132.06K£ 74.76K£ 0.00
Gross Profit£ 2.71M£ 683.04K£ 85.19K£ 45.34K£ -5.05K
Operating Income£ -826.79K£ -2.90M£ -3.00M£ -2.98M£ -1.49M
EBITDA£ -196.54K£ -2.72M£ -2.96M£ -2.95M£ -1.49M
Net Income£ -696.25K£ -2.88M£ -2.84M£ -2.79M£ -1.43M
Balance Sheet
Cash & Short-Term Investments£ 4.78M£ 800.90K£ 1.31M£ 1.80M£ 4.61M
Total Assets£ 12.13M£ 5.22M£ 2.59M£ 3.08M£ 5.73M
Total Debt£ 993.47K£ 818.74K£ 100.65K£ 127.86K£ 139.85K
Net Debt£ -3.79M£ 17.84K£ -1.21M£ -1.68M£ -4.47M
Total Liabilities£ 2.71M£ 2.25M£ 599.34K£ 609.61K£ 519.67K
Stockholders' Equity£ 9.42M£ 2.97M£ 1.99M£ 2.48M£ 5.22M
Cash Flow
Free Cash Flow£ -1.30M£ -2.92M£ -2.81M£ -2.77M£ -1.67M
Operating Cash Flow£ -1.30M£ -2.73M£ -2.65M£ -2.67M£ -1.56M
Investing Cash Flow£ -1.62M£ -2.30M£ -165.28K£ -96.81K£ -112.31K
Financing Cash Flow£ 6.90M£ 4.51M£ 2.32M£ -35.12K£ 4.12M
Currency in GBP

SkinBioTherapeutics Earnings and Revenue History

SkinBioTherapeutics Debt to Assets

SkinBioTherapeutics Cash Flow

SkinBioTherapeutics Forecast EPS vs Actual EPS